Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
The usefulness of particle beams for radiation therapy has been well and widely recognized. For the cure of cancer patients, many accelerator facilities have already been utilized, and some new facilities are now being put into operation, or are under construction. Considering the medical and biological requirements, light heavy ions with an energy of several hundred MeV/nucleon are regarded as being the most suitable species. A reasonable choice to this end is an accelerator complex, for an example, one comprising an ion source, an injector linac, and a synchrotron. The ion source is of great importance, since its characteristics strongly affect the overall performance of the accelerator system. A pulsed Penning source (PIGIS) has been successfully used at Lawrence Berkeley Laboratory. Recently, at the National Institute of Radiological Sciences a low-duty pulsed PIGIS for the heavy-ion medical accelerator in Chiba (HIMAC) has been developed; it has both a long lifetime and a high peak intensity. As other types of ion sources, an electron-beam ion source (EBIS) and an electron-cyclotron-resonance ion source (ECRIS) are being developed at several laboratories. An EBIS is basically a pulsed source, and is being successfully used at Saclay. By using an after-glow mode, two ECRISs have made remarkable progress at Grenoble and the Grand Accelerateur National d’Ions Lourds; similar tests are proceeding for the Schwer-Ionen Synchrotron at the Gesellschaft für Schwer-Ionenforschung, the booster at Centre d’Europeen de Recherche Nucleaire, and the HIMAC. These different types of heavy-ion sources are discussed from the viewpoint of their application to radiation therapy.
The usefulness of particle beams for radiation therapy has been well and widely recognized. For the cure of cancer patients, many accelerator facilities have already been utilized, and some new facilities are now being put into operation, or are under construction. Considering the medical and biological requirements, light heavy ions with an energy of several hundred MeV/nucleon are regarded as being the most suitable species. A reasonable choice to this end is an accelerator complex, for an example, one comprising an ion source, an injector linac, and a synchrotron. The ion source is of great importance, since its characteristics strongly affect the overall performance of the accelerator system. A pulsed Penning source (PIGIS) has been successfully used at Lawrence Berkeley Laboratory. Recently, at the National Institute of Radiological Sciences a low-duty pulsed PIGIS for the heavy-ion medical accelerator in Chiba (HIMAC) has been developed; it has both a long lifetime and a high peak intensity. As other types of ion sources, an electron-beam ion source (EBIS) and an electron-cyclotron-resonance ion source (ECRIS) are being developed at several laboratories. An EBIS is basically a pulsed source, and is being successfully used at Saclay. By using an after-glow mode, two ECRISs have made remarkable progress at Grenoble and the Grand Accelerateur National d’Ions Lourds; similar tests are proceeding for the Schwer-Ionen Synchrotron at the Gesellschaft für Schwer-Ionenforschung, the booster at Centre d’Europeen de Recherche Nucleaire, and the HIMAC. These different types of heavy-ion sources are discussed from the viewpoint of their application to radiation therapy.
The current status of the ITEP proton and ion accelerator complex which is being created now on bhe base of the tTEP 10 GeV Proton Synchrotron is described. The paper includes also a brief overview of the ITEP accelerator complex future development plans which are under intensive discussion now. One o of the p r' 0 pas c\ 1:::' un c! E~tdis c u s~; ion i S~+..: h e con s t r u c t ion o~: an
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.